| Strength: | |
|---|---|
| Quantity: | |
Brief Introduction:
National Medical Insurance, Category B.
Launched in 2005.
National standard bulk supplier of rHuIL-11.
Participated in the development and collaborative calibration of rHuIL-11 national reference standards.
Indications:
Severe thrombocytopenia with degree III and IV induced by chemotherapy to solid tumor and to non-marrow leukemia.
